A Prospective Study of Concurrent Cyclophosphamide/Methotrexate/5-Fluorouracil and Reduced-Dose Radiotherapy in Patients with Early-Stage Breast Carcinoma

Cancer

Volumn 100, Issue 7, 2004, Pages 1358-1364

  Bellon, Jennifer R ^a   Shulman, Lawrence N ^a   Come, Steven E ^b   Li, Xiaochun ^c   Gelman, Rebecca S ^a,c   Silver, Barbara J ^a   Harris, Jay R ^a   Recht, Abram ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Breast; Concurrent; Cyclophosphamide methotrexate 5 fluorouracil; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIOSENSITIZATION; SURVIVAL RATE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIATION DOSAGE; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1642380371     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20136     Document Type: Article

References (39)

1. Hartsell WF, Recine DC, Griem KL, et al. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer. 1995;76:2497-2503.
2. Buchholz TA, Austin-Seymour MM, Moe RE, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1993;26:23-35.
3. Recht A, Come SE, Gelman RS, et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol. 1991;9:1662-1667.
4. Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 1996;334:1356-1361.
5. Bellon J, Come S, Gelman R, et al. Sequencing of chemotherapy with radiation therapy in early stage breast cancer: updated results of a prospective randomized trial [abstract]. Int J Radiat Oncol Biol Phys. 2001;51(Suppl 1):2-3.
6. Milross CG, Mason KA, Hunter NR, et al. Enhanced radio-response of paclitaxel-sensitive and -resistant tumours in vivo. Eur J Cancer. 1997;33:1299-1308.
7. Bonner JA, Raisch KP, Trummell HQ, et al. Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers. J Clin Oncol. 2000;18(21 Suppl):47S-53S.
8. Protiere C, Viens P, Genre D, et al. Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancer. Ann Oncol. 2000;11:39-45.
9. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst. 1996;88:1210-1215.
10. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593-1598.
11. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
12. Cafiero F, Gipponi M, Peressini A, et al. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer. J Surg Oncol. 2000;75:80-88.
13. Bellon JR, Lindsley KL, Ellis GK, et al. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int J Radiat Oncol Biol Phys. 2000;48:393-397.
14. Taghian AG, Assaad SI, Niemierko A, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Nalt Cancer Inst. 2001;93:1806-1811.
15. Hanna YM, Baglan KL, Stromberg JS, et al. Acute and sub-acute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J. 2002;8:149-153.
16. Lingos TI, Recht A, Vicini F, et al. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21:355-360.
17. Abner AL, Recht A, Vicini FA, et al. Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1991;21:331-338.
18. Dubey A, Recht A, Come SE, et al. Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study. Int J Radiat Oncol Biol Phys. 1999;45:877-884.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
20. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
21. Bonadonna G, Valagussa P, Moliterni A, et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med. 1995;332:901-916.
22. Fisher B, Dignam J, Mamounas EP, et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol. 1996;14:1982-1992.
23. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
24. Lamb D, Atkinson C, Joseph D, et al. Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer. Australas Radiol. 199;43:220-226.
25. Markiewicz DA, Fox KR, Schultz DJ, et al. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer. Cancer J Sci Am. 1998;4:185-193.
26. Assersohn L, Powles TJ, Ashley S, et al. Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Ann Oncol. 1999;10:1451-1455.
27. Calais G, Serin D, Fourquet A, et al. Randomized study comparing adjuvant radiotherapy with concomitant chemotherapy versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma [abstract]. Int J Radiat Oncol Biol Phys 2002;54(Suppl 2):57-58.
28. Rouesse J, Cvitkovic F, De Lalande B, et al. Concomitant or sequential chemoradiotherapy (CRT) in operable breast cancer. Final results of a French multicentric phase III study [abstract]. Breast Cancer Res Treat. 2002;76:S160.
29. Neuschatz AC, DiPetrillo T, Safaii H, et al. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer. 2003;97:30-39.
30. Obedian E, Haffty BG. Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am. 2000;6:28-33.
31. Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999;44:1005-1015.
32. Isaac N, Panzarella T, Lau A, et al. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen. Cancer. 2002;95:696-703.
33. Fernando IN, Powles TJ, Ashley S, et al. An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery. Clin Oncol. 1996;8:234-238.
34. Winer EP, Burstein HJ, Galper S, et al. Prospective phase I evaluation of concurrent paclitaxel and breast radiation therapy following adjuvant doxorubicin/cyclophosphamide (AC) chemotherapy for stage II/III breast cancer [abstract]. Proc Am Soc Clin Oncol. 2001;20:39a.
35. Markiewicz DA, Schultz DJ, Haas JA, et al. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. Int J Radiat Oncol Biol Phys. 1996;35:661-668.
36. Faul C, Brufsky A, Gerszten K, et al. Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery. Eur J Cancer. 2003;39:763-768.
37. Moro G, Stasi M, Borca V. Does concomitant chemoradiotherapy influence cosmetic outcome in conservative treatment of breast cancer? Tumori. 1997;83:743-747.
38. Borger JH, Keijser AH. Conservative breast treatment: analysis of cosmetic results and the role of concomitant adjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 1987;13:1173-1177.
39. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:1336-1344.